ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q1SCImago #2,695Hybrid

Hematology-Oncology Clinics of North America

Abbreviation (ISO):HEMATOL ONCOL CLIN N
•
Identifier (ISSN):0889-8588(Print)/1558-1977(Online)
•
Publisher:W.B. Saunders Ltd
Clarivate IF (2026)
3.1↑ +0.4
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Hematology-Oncology Clinics of North America

WoS Q2
12453.120182.8820193.1120203.7220212.8620222.420232.520242.720253.12026
Annual Impact Factor Metric
Current (2026):3.1
Scopus SJR & RankScopus Q1
1.415
#2,695

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
103

103 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
91articles/year
2.65% Gold OA•100% Original Research

Aims & Scope

Hematology/Oncology Clinics updates you on the latest trends in patient management, keeps you up to date on the newest advances, and provides a sound basis for choosing treatment options. Under the direction of an experienced guest editor, each issue focuses on a single topic in hematology and oncology, including hemostasis and thrombosis, molecular and cellular basis of hematology, coagulation disorders, and cancers—bone, gastrointestinal, head and neck, lymphomas, neuroendocrine, breast, renal cell, melanoma, and more.

Topics Covered (Recognized by AI)
Medicine77.4%Biology72.2%Internal medicine70.7%Genetics57.9%Pathology49.7%Immunology43%Surgery35.2%Chemistry29.2%Biochemistry26%Cancer24.8%Psychology24%Oncology23%Disease21.3%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

HEMATOLOGY

Q2
Rank37/103
IndexSCIE
JCRSCIE2026

ONCOLOGY

Q2
Rank165/333
IndexSCIE
JCISCIE2026

HEMATOLOGY

Q2
Rank31/103
IndexSCIE
JCISCIE2026

ONCOLOGY

Q2
Rank139/333
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3.1
Articles / Year51
Total Citations29
2025
IF2.7
Articles / Year103
Total Citations176
2024
IF2.5
Articles / Year121
Total Citations477
2023
IF2.4
Articles / Year134
Total Citations1,101
2022
IF2.861
Articles / Year112
Total Citations1,221

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #2,695Scopus Q1SCImago Profile
Scopus Coverage:1987-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q1
1.415

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
2.78

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,347 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations859
3-Year Documents278
Citable Documents239

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate46.9%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

HematologyQ1
OncologyQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Hematology-Oncology Clinics of North America (abbr: HEMATOL ONCOL CLIN N, ISSN: 0889-8588) is a peer-reviewed international scholarly journal in the field of Medicine, published by W.B. Saunders Ltd in United States since 1987. The periodical holds a Journal Impact Factor (JIF) of 3.10, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 1.415 (Q1), an H-index of 103.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 91 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,347 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
W.B. Saunders Ltd
Publication Language
English
Frequency
Bimonthly
Founding Year
1987
Indexing & Databases
SCIEScopusPubMed
Editorial Address
W B SAUNDERS CO-ELSEVIER INC, 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, USA, PA, 19103-2899

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: a4d89f4c-7fe9-4f1d-835f-20ff6d2d183f
Database Updated: 2026-10-16